| ★ | What Does New Phase 3 Amlitelimab Data Suggest for Atopic Dermatitis? | | 92 | Estados Unidos | |
| 4 | How New Biologics Are Changing #AtopicDermatitis Treatment | | 274 | Estados Unidos | 88 |
| 5 | How New Biologics Are Changing #AtopicDermatitis Treatment | | 272 | Estados Unidos | 88 |
| 20 | Recent AAD Guidelines Address Pediatric Atopic Dermatitis Prevention | | 233 | Estados Unidos | 86 |
| 3 | Highlighting FDA-Approved Therapies in Atopic Dermatitis, With Chris Bunick, MD, PhD | | 152 | Estados Unidos | 89 |
| 7 | How Are New Biologics Changing Atopic Dermatitis Treatment? | | 137 | Estados Unidos | 87 |
| 8 | What is on the Horizon for Pediatric #AtopicDermatitis Treatment | | 111 | Estados Unidos | 87 |
| 14 | What EASI 75, vIGA-AD Scores Reveal About Tapinarof's Eczema Efficacy | | 103 | Estados Unidos | 86 |
| 17 | Ruxolitinib, Tapinarof, Roflumilast: What's New for Pediatric AD | | 102 | Estados Unidos | 86 |
| 1 | What Is Next for OX40 Ligand Inhibition in Atopic Dermatitis? | | 91 | Estados Unidos | 96 |
| 11 | Prior Authorization, Precision Medicine, and Eczema Remission, With Jason Hawkes, MD | | 69 | Estados Unidos | 86 |
| 12 | Discussing Current Treatment Options for Atopic Dermatitis, With Peter Lio, MD | | 68 | Estados Unidos | 86 |
| 6 | Age-Stratified Phase 3 Data Support Tapinarof Cream in Pediatric Eczema | | 58 | Estados Unidos | 88 |
| 10 | ADorable-1 Results: Key Findings in Pediatric Atopic Dermatitis | | 58 | Estados Unidos | 86 |
| 15 | Can CSU Patients Achieve True Remission? BTK Inhibitors, Biomarker Barriers, & More | EAC 2026 | | 58 | Estados Unidos | 86 |
| 2 | Discussing Zumilokibart Data in Atopic Dermatitis, With Ruth Ann Vleugels, MD, MPH, MBA | | 30 | Estados Unidos | 90 |
| 9 | What is the Most Contested Issue in Atopic Dermatitis Today? With Mona Shahriari, MD | | 29 | Estados Unidos | 87 |
| 16 | Emerging Evidence in Atopic Dermatitis Management, With Harrison Nguyen, MD, MBA, MPH | | 23 | Estados Unidos | 86 |
| 19 | Delgocitinib & Hand Eczema: How Topical JAK Inhibitors Change the Treatment Sequence | Maui Derm | | 11 | Estados Unidos | 86 |
| 18 | Individualizing Treatment Selection in Atopic Dermatitis, With Harrison Nguyen, MD, MBA, MPH | | 9 | Estados Unidos | 86 |
| 13 | Evolving Safety Considerations in Atopic Dermatitis Management | | 3 | Estados Unidos | 86 |